PLK1 and breast carcinoma: Importantly, PLK1 has been shown to play a role in mediating tamoxifen resistance in ER+ breast cancer cells, and thus we will conduct additional studies evaluating the role of PLK1 as a novel target for the ER+ breast cancer resistant to CDK4/6 inhibition [32].